Guanine nucleotide-binding protein-like 2 (nucleolar) pseudogene 1 (GNL2P1)

GNL2P1 is classified as a pseudogene—a non-functional genomic DNA sequence similar to a gene but normally lacking the capacity to produce a functional protein[2][4]. Pseudogenes generally arise from duplication or retrotransposition events and subsequently acquire mutations that disrupt their coding potential. Some pseudogenes are transcribed and can exert regulatory effects on their parental or related genes through RNA-mediated mechanisms (such as acting as competing endogenous RNAs or generating small interfering RNAs), but there is no documented evidence of such specific regulatory activity for GNL2P1[2][4]. It is not considered a therapeutic target, nor does it encode a receptor, enzyme, or other druggable entity. No drugs or biomarkers are associated with GNL2P1, and there are no known safety concerns or therapeutic challenges, since it has no direct function in cell signaling, metabolism, or disease biology. The term "receptor" or "target" in relation to GNL2P1 is incorrect; it should be referred to as a processed pseudogene under current nomenclature and understanding.

Other names

GNL2P1guanine nucleotide binding protein-like 2 (nucleolar) pseudogene 1